No Data
Emerging markets outlook: Will the Growth Market 250 Index attempt to exceed 25MA after the US presidential election?
Breaking through the resistance line may improve investor sentiment as emerging markets rose this week. During the same period, while the Nikkei Average increased by +0.37%, the Growth Market Index rose by +4.98% and the Growth Market 250 Index by +5.20%, highlighting the strength of growth markets. The attention-grabbing House of Representatives election resulted in the ruling party falling below the majority, however, the market had already priced in this outcome, leading to a trend of dominant buybacks in the Tokyo market. The progressing Democratic Party for the People is expected to take over the government.
The TOPIX Growth Market 250 index fell for the first time in 5 days, influenced by the backlash against the recent rise.
The Tokyo Stock Exchange Growth Market Index is 794.83, -12.24 / Volume 0.1 billion 80.83 million shares / Trading value 104.5 billion yen. The Tokyo Stock Exchange Growth Market 250 Index is 619.96, -10.32 / Volume 79.53 million shares / Trading value 78.9 billion yen. Today's growth market, both the Tokyo Stock Exchange Growth Market Index and the Tokyo Stock Exchange Growth Market 250 Index, fell for the first time in 5 days. There were 125 rising issues, 426 declining issues, and 32 unchanged. The US stock market on October 31st continued to decline. The Dow Jones average was down 378.
SBI SECURITIES decrases its stake in DREAM VISION(3185.JP) to 8.7%
On Oct 31, SBI SECURITIES submitted the Change Report to Ministry of Finance. The report shows that SBI SECURITIES decreased their holdings in $DREAM VISION(3185.JP)$, with their joint shareholding
The TOPIX Growth Market 250 index continues to rise significantly, with funds flowing into leading stocks.
The TSE Growth Market Index was 797.93, up 16.23 points / with a volume of 0.23622 billion shares / trading value of 102.3 billion yen. The TSE Growth Market 250 Index was 622.54, up 12.66 points / with a volume of 84.11 million shares / trading value of 61.3 billion yen. Today's growth market saw significant gains in both the TSE Growth Market Index and the TSE Growth Market 250 Index. The number of rising stocks was 424, falling stocks 130, and unchanged 33. The U.S. stock market on the 28th rose. The Dow Jones Industrial Average rose by 273.17 points.
Medrek, Replcell, and others
Dream Vision's 11th subscription rights (with exercise price adjustment clause) will issue a large amount of shares starting from the 28th, with 0.5 million shares. MedRx MRX-7MLL <4586> has started clinical trials. OncoLis Bio's 20th subscription rights (with exercise price adjustment clause) will issue a large amount of shares starting from the 18th, with 0.512 million shares. Progress of clinical phases 1/2 trials for DELTA-PDF-10917 and VEN <4598>. Modalis's 14th subscription rights.
SBI SECURITIES decrases its stake in DREAM VISION(3185.JP) to 10.29%
On Oct 28, SBI SECURITIES submitted the Change Report to Ministry of Finance. The report shows that SBI SECURITIES decreased their holdings in $DREAM VISION(3185.JP)$, with their joint shareholding
No Data
No Data